These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33371058)

  • 1. Comparison of empirical high-dose and low-dose of meropenem in critically ill patients with sepsis and septic shock: A randomized controlled study protocol.
    Ye X; Wang F; Zeng W; Ding Y; Lv B
    Medicine (Baltimore); 2020 Dec; 99(51):e22829. PubMed ID: 33371058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Meropenem Extended Versus Intermittent Infusion Dosing Protocol in Critically Ill Patients.
    Ahmed N; Jen SP; Altshuler D; Papadopoulos J; Pham VP; Dubrovskaya Y
    J Intensive Care Med; 2020 Aug; 35(8):763-771. PubMed ID: 29954243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meropenem Administration in Critically Ill Patients With Sepsis.
    Jabareen A; Kurnik D
    JAMA; 2023 Nov; 330(18):1801. PubMed ID: 37962659
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of a loading dose of meropenem on outcomes of patients with sepsis treated by continuous renal replacement: study protocol for a randomized controlled trial.
    Ni SQ; Teng WB; Fu YH; Su W; Yang Z; Cai J; Xu JN; Deng XY; Liu XF; Fu SN; Zeng J; Zhang C
    Trials; 2022 Apr; 23(1):294. PubMed ID: 35413886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem Administration in Critically Ill Patients With Sepsis-Reply.
    Monti G; Redaelli MB; Zangrillo A
    JAMA; 2023 Nov; 330(18):1801-1802. PubMed ID: 37962655
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial.
    Monti G; Bradic N; Marzaroli M; Konkayev A; Fominskiy E; Kotani Y; Likhvantsev VV; Momesso E; Nogtev P; Lobreglio R; Redkin I; Toffoletto F; Bruni A; Baiardo Redaelli M; D'Andrea N; Paternoster G; Scandroglio AM; Gallicchio F; Ballestra M; Calabrò MG; Cotoia A; Perone R; Cuffaro R; Montrucchio G; Pota V; Ananiadou S; Lembo R; Musu M; Rauch S; Galbiati C; Pinelli F; Pasin L; Guarracino F; Santarpino G; Agrò FE; Bove T; Corradi F; Forfori F; Longhini F; Cecconi M; Landoni G; Bellomo R; Zangrillo A;
    JAMA; 2023 Jul; 330(2):141-151. PubMed ID: 37326473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
    Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
    BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Dosing of Meropenem in a Small Cohort of Critically Ill Children Receiving Continuous Renal Replacement Therapy.
    Tan WW; Watt KM; Boakye-Agyeman F; Cohen-Wolkowiez M; Mok YH; Yung CF; Chan YH
    J Clin Pharmacol; 2021 Jun; 61(6):744-754. PubMed ID: 33314163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
    Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM
    Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
    Landersdorfer CB; Nation RL
    Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-volume haemofiltration for sepsis in adults.
    Borthwick EM; Hill CJ; Rabindranath KS; Maxwell AP; McAuley DF; Blackwood B
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD008075. PubMed ID: 28141912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
    Turgeon AF; Hutton B; Fergusson DA; McIntyre L; Tinmouth AA; Cameron DW; Hébert PC
    Ann Intern Med; 2007 Feb; 146(3):193-203. PubMed ID: 17283351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trial.
    Roggeveen LF; Fleuren LM; Guo T; Thoral P; de Grooth HJ; Swart EL; Klausch TLT; van der Voort PHJ; Girbes ARJ; Bosman RJ; Elbers PWG
    Trials; 2019 Dec; 20(1):745. PubMed ID: 31852491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
    Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
    Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are β-lactam concentrations adequate in severe sepsis and septic shock in children?
    Chosidow A; Benaboud S; Beranger A; Zheng Y; Moulin F; Dupic L; Renolleau S; Treluyer JM; Oualha M
    Therapie; 2020; 75(6):633-640. PubMed ID: 32593420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.
    Prkno A; Wacker C; Brunkhorst FM; Schlattmann P
    Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact on Efficacy and Safety of Hydrocortisone in Sepsis and Septic Shock - A Systematic Literature Review and Meta-analysis.
    Aletreby WT; Alharthy AM; Madi AF; Soliman IR; Hamido HM; Ramadan OE; Alzayer W; Huwait BM; Alodat MA; Mumtaz SA; Mahmood NN; Al Kurdi MH; Farrag HA; Karakitsos D
    Arch Iran Med; 2019 Jul; 22(7):394-402. PubMed ID: 31679383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.